Talking back to prozac
what doctors won't tell you about today's most controversial drug
By Peter Roger Breggin

"Talking back to prozac" is published by St. Martin's Press in 1994 - New York, it has 273 pages and the language of the book is English.
“Talking back to prozac” Metadata:
- Title: Talking back to prozac
- Author: Peter Roger Breggin
- Language: English
- Number of Pages: 273
- Publisher: St. Martin's Press
- Publish Date: 1994
- Publish Location: New York
“Talking back to prozac” Subjects and Themes:
- Subjects: ➤ Antipsychiatry - Fluoxetine - Moral and ethical aspects - Moral and ethical aspects of Fluoxetine - Personality change - Side effects - Social aspects - Social aspects of Fluoxetine - Psychofarmaca - Personality Disorders - Adverse effects - Chemically induced
Edition Specifications:
- Pagination: xiv, 273 p. :
Edition Identifiers:
- The Open Library ID: OL1088522M - OL522952W
- Online Computer Library Center (OCLC) ID: 30475324
- Library of Congress Control Number (LCCN): 94012572
- ISBN-10: 0312114869
- All ISBNs: 0312114869
AI-generated Review of “Talking back to prozac”:
"Talking back to prozac" Description:
The Open Library:
Prozac. Millions of Americans are on it. And just about everyone else is wondering if they should be on it, too. The claims of the pro-Prozac chorus are enticing: that it can cure everything from depression (the only disorder for which Prozac was originally approved) to fear of public speaking, PMS, obesity, shyness, migraine, and back pain - with few or no side effects. But is the reality quite different? At what price do we buy Prozac-induced euphoria and a shiny new personality? Psychiatrist Peter Breggin, M.D., and coauthor Ginger Ross Breggin answer these and other crucial questions in Talking Back to Prozac. They explain what Prozac is and how it works. And they take a hard look at the real story behind today's most controversial drug: the fact that Prozac was tested in trials of four to six weeks in length before receiving FDA approval; the difficulty Prozac's manufacturer had in proving its effectiveness during these tests; the information on side effects that the FDA failed to include in its final labeling requirements; how Prozac acts as a stimulant not unlike the addictive drugs cocaine and amphetamine; the dangers of possible Prozac addiction and abuse; the seriousness and frequency of Prozac's side effects, including agitation, insomnia, nausea, diarrhea, loss of libido, and difficulty reaching orgasm; the growing evidence that Prozac can cause violence and suicide; and the social and workplace implications of using the drug not to cure depression but to change personality and enhance performance. Using dramatic case histories as well as scientific research and carefully documented evidence, the Breggins expose the potentially damaging effects of Prozac. They also describe the resounding success that has been achieved with more humane alternatives for the treatment of depression. Talking Back to Prozac provides essential information for anyone who takes Prozac or is considering taking it, and for those who prescribe it.
Read “Talking back to prozac”:
Read “Talking back to prozac” by choosing from the options below.
Search for “Talking back to prozac” downloads:
Visit our Downloads Search page to see if downloads are available.
Borrow "Talking back to prozac" Online:
Check on the availability of online borrowing. Please note that online borrowing has copyright-based limitations and that the quality of ebooks may vary.
- Is Online Borrowing Available: Yes
- Preview Status: borrow
- Check if available: The Open Library & The Internet Archive
Find “Talking back to prozac” in Libraries Near You:
Read or borrow “Talking back to prozac” from your local library.
- The WorldCat Libraries Catalog: Find a copy of “Talking back to prozac” at a library near you.
Buy “Talking back to prozac” online:
Shop for “Talking back to prozac” on popular online marketplaces.